GGrantIndex
← Search

Development of Therapeutic Products for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases

$185,160N01FY2024AINIH

Venatorx Pharmaceuticals, Inc., Malvern PA

Investigators

View original record on NIH RePORTER →